A leaked forensic report has raised questions over EOH’s dealings with the government — at a time when the company has yet to regain the lustre that once made it a market darling. The information technology company’s share price has lost more than 60% over the past year after allegations of corruption involving an SA Social Security Agency (Sassa) contract surfaced. This was followed by more allegations of corruption involving a company it acquired, Forensic Data Analysts (FDA), run by controversial businessman Keith Keating. The financial performance of EOH has also weighed on its share price after the 23% slump in earnings the company reported for its half-year to end-January. These developments prompted a return of founder Asher Bohbot. The company cleared itself of wrongdoing involving the Sassa contract and reversed the transaction with FDA. EOH also has plans to split its business into two parts, with EOH’s CEO Zunaid Mayet opting to step down from that post and lead Nextec, a...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.